These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 16790993)
41. Right brain: my first tPA. Robbins MS Neurology; 2009 Jul; 73(2):e9-e10. PubMed ID: 19597130 [No Abstract] [Full Text] [Related]
42. Door-to-needle times in acute ischemic stroke: how low can we go? Smith EE; von Kummer R Neurology; 2012 Jul; 79(4):296-7. PubMed ID: 22622861 [No Abstract] [Full Text] [Related]
43. IV thrombolysis for acute ischemic stroke: Is there a paradigm shift on the horizon? Barrett KM; Gottesman RF Neurology; 2016 Jul; 87(2):132-3. PubMed ID: 27306635 [No Abstract] [Full Text] [Related]
44. Should more patients with acute ischaemic stroke receive thrombolytic treatment? Wardlaw JM; Sandercock PA; Murray V BMJ; 2009 Nov; 339():b4584. PubMed ID: 19906748 [No Abstract] [Full Text] [Related]
45. Re: Recanalization after intravenous thrombolysis: does a recanalization time window exist? Gotkine M; Rosenberg G; Steiner I Neurology; 2008 Jan; 70(5):406; author reply 406-7. PubMed ID: 18227425 [No Abstract] [Full Text] [Related]
46. Reasons for exclusion from thrombolytic therapy following acute ischemic stroke. Schestatsky P; Picon PD Neurology; 2005 Dec; 65(11):1844; author reply 1844. PubMed ID: 16344546 [No Abstract] [Full Text] [Related]
47. Further randomized controlled trials of tPA within 3 hours are required-not! Lyden PD Stroke; 2001 Nov; 32(11):2709-10. PubMed ID: 11692041 [No Abstract] [Full Text] [Related]
49. [Thrombolysis in stroke--rush is good but do not forget the pharmacology!]. Andsberg G; Norrving B Lakartidningen; 2013 Feb 20-26; 110(8):423. PubMed ID: 23488443 [No Abstract] [Full Text] [Related]
50. [The management of stroke in France, a new stake in the organisation of hospital care]. Giroud M; Osseby GV Presse Med; 2004 Mar; 33(5):293-4. PubMed ID: 15041872 [No Abstract] [Full Text] [Related]
51. Efficacy and safety profile of the carotenoid trans sodium crocetinate administered to rabbits following multiple infarct ischemic strokes: a combination therapy study with tissue plasminogen activator. Lapchak PA Brain Res; 2010 Jan; 1309():136-45. PubMed ID: 19891959 [TBL] [Abstract][Full Text] [Related]
52. Pinocembrin Protects Blood-Brain Barrier Function and Expands the Therapeutic Time Window for Tissue-Type Plasminogen Activator Treatment in a Rat Thromboembolic Stroke Model. Ma Y; Li L; Kong L; Zhu Z; Zhang W; Song J; Chang J; Du G Biomed Res Int; 2018; 2018():8943210. PubMed ID: 29850586 [TBL] [Abstract][Full Text] [Related]